Genetic Test Predicts Breast Cancer Recurrence
Test Helps Determine Need for Chemotherapy
Judy Perotti, who faced the agonizing decision of whether to undergo chemotherapy when she was diagnosed with a new breast cancer about a year ago, says she wishes the test had been available to her.
"All the other measures were all jumbled up and I ended up deciding to have chemotherapy even though I really didn't want to," she says.
Perotti, a breast cancer advocate with the Research Advocacy Network in Arlington Heights, Ill., recommends the test be used in conjunction with traditional markers, not instead of them.
"It's once more piece of information I could have used in making my decision," she says.
Genomic Health, which makes the test, expects it to be available in early 2004. The price has not yet been determined.